| NOTE 15 - | OPTIONS PLANS |
| a. | Options plan adopted by the Company and its subsidiaries: |
| 1. | On October 13, 2016, the Company’s general meeting adopted option plan to the Company’s executive Chairmen of the board (“The Chairman”). According to the plan, the Chairman was granted options exercisable into 38,445 ordinary shares, no par value, of the Company, constituting approximately 0.4% of the Company’s issued and outstanding share capital on a fully diluted basis. The exercise price of the options is equal to NIS 13.426 per share. The option term is for 5 years and it will be vested equally over a period of 3 years. |
| 2. | Elbit Medical plan: |
| Year ended December 31 | |||||||||||||||||
| 2017 | 2016 | ||||||||||||||||
| Number of options | Weighted average exercise price | Number of options | Weighted average exercise price | ||||||||||||||
| (NIS) | (NIS) | ||||||||||||||||
| Balance at the beginning of the year | 158,592,747 | 0.14 | 140,035,935 | 0.14 | |||||||||||||
| Granted (1) | 500,000 | 0.13 | 22,298,912 | 0.10 | |||||||||||||
| Forfeited | (104,685,257 | ) | 0.13 | (3,742,100 | ) | 0.40 | |||||||||||
| Exercised | (36,670,449 | ) | 0.13 | - | - | ||||||||||||
| Balance at the end of the year | 17,737,041 | 0.11 | 158,592,747 | 0.11 | |||||||||||||
| Options exercisable at the year end | 2,371,100 | 0.13 | 136,293,835 | 0.13 | |||||||||||||
| 3. | Includes 8,199,275 options granted to the Company’s Chairman of the Board on October 13, 2016 for a period of 5 years and an exercise price of NIS 0.106 per option. The options will be vested equally over a period of 3 years. |
| b. | Options plan adopted by PC: |
Over the years, the PC has adopted few option plans over its shares. The below table summarized the significant terms in respect of PC’s option plans as for December 31, 2017
| Number of options | Max exercisable number of shares | average exercise price | Vested as of December 31, 2017 | average contractual life | Option granted to key personnel | |||||||
| PC’s plan | 235,520 | 356,781 | GBP 43 | 253,520 | 5.06 years | 30,000 |